[The effect of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on human erythrocytes].
Moriguchi
T
T
Kakita
T
T
Nishimura
T
T
Kubo
A
A
Ueda
T
T
Nakamura
T
T
Sasada
M
M
Uchino
H
H
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001799:Blood Sedimentation; D003561:Cytarabine / Q000031:analogs & derivatives* / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects*; D006801:Humans; D007938:Leukemia / Q000097:blood* / Q000188:drug therapy; D009996:Osmotic Fragility / Q000187:drug effects
D000970:Antineoplastic Agents; D003561:Cytarabine; C015019:enocitabine